scholarly article | Q13442814 |
P50 | author | Carl Figdor | Q16318725 |
Ruurd Torensma | Q37378257 | ||
Bastiaan J. Jansen | Q73419426 | ||
P2093 | author name string | Gosse J Adema | |
Lieke C J van den Berk | |||
Helene Roelofs | |||
Kim G C Siebers-Vermeulen | |||
P2860 | cites work | The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games | Q24683018 |
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 | ||
The TNF and TNF receptor superfamilies: integrating mammalian biology | Q28203717 | ||
MethPrimer: designing primers for methylation PCRs | Q29618664 | ||
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli | Q29618769 | ||
Replicative senescence of mesenchymal stem cells: a continuous and organized process | Q33336408 | ||
Stimulus-specific assembly of enhancer complexes on the tumor necrosis factor alpha gene promoter | Q33786998 | ||
Interindividual concordance of methylation profiles in human genes for tumor necrosis factors alpha and beta | Q33893937 | ||
A CAT reporter construct allows ultrasensitive estimation of TNF synthesis, and suggests that the TNF gene has been silenced in non-macrophage cell lines | Q34183889 | ||
Gender differences in injury induced mesenchymal stem cell apoptosis and VEGF, TNF, IL-6 expression: role of the 55 kDa TNF receptor (TNFR1). | Q35606632 | ||
Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells | Q36350042 | ||
Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level | Q36350458 | ||
Extinction of the tumor necrosis factor locus, and of genes encoding the lipopolysaccharide signaling pathway | Q36361659 | ||
A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential | Q36399846 | ||
Mesenchymal stromal cells: tissue engineers and immune response modulators | Q37287391 | ||
DNA methylation profiles in the human genes for tumor necrosis factors alpha and beta in subpopulations of leukocytes and in leukemias | Q37541346 | ||
Tumor necrosis factor alpha gene regulation in activated T cells involves ATF-2/Jun and NFATp | Q40018125 | ||
Cell-type-specific regulation of the human tumor necrosis factor alpha gene in B cells and T cells by NFATp and ATF-2/JUN. | Q40019878 | ||
Cell surface 4-1BBL mediates sequential signaling pathways 'downstream' of TLR and is required for sustained TNF production in macrophages. | Q40133919 | ||
Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo | Q40662801 | ||
Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses | Q42575579 | ||
Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice | Q42826405 | ||
Depot-specific differences in adipogenic progenitor abundance and proliferative response to high-fat diet | Q43297876 | ||
Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells. | Q44698226 | ||
Role of toll-like receptors on human adipose-derived stromal cells. | Q51147826 | ||
Cytokine production and hematopoiesis supporting activity of cord blood-derived unrestricted somatic stem cells. | Q51492530 | ||
In vitro differentiation of cord blood unrestricted somatic stem cells expressing dopamine-associated genes into neuron-like cells. | Q51998050 | ||
Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. | Q52008649 | ||
P433 | issue | 2 | |
P921 | main subject | mesenchymal stem cell | Q1922379 |
TNF | Q18032037 | ||
P304 | page(s) | 283-289 | |
P577 | publication date | 2009-11-06 | |
P1433 | published in | Journal of Leukocyte Biology | Q1524048 |
P1476 | title | Mesenchymal stem cells respond to TNF but do not produce TNF | |
P478 | volume | 87 |
Q90568420 | Blood glutamate EAAT2-cell grabbing therapy in cerebral ischemia |
Q43117359 | Bone-marrow mesenchymal stem cells reduce rat intestinal ischemia-reperfusion injury, ZO-1 downregulation and tight junction disruption via a TNF-α-regulated mechanism |
Q35195144 | Comparison of Gene Expression in Human Embryonic Stem Cells, hESC-Derived Mesenchymal Stem Cells and Human Mesenchymal Stem Cells |
Q26782203 | Complement activation in the context of stem cells and tissue repair |
Q42724367 | Cord blood mesenchymal stem cells suppress DC-T Cell proliferation via prostaglandin B2. |
Q38756773 | Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy |
Q42108485 | Differential Expression of Insulin-Like Growth Factor-I Receptor on Human Bone Marrow-Derived Mesenchymal Stem Cells Induced by Tumor Necrosis Factor-α. |
Q34510799 | Differential expression of surface markers in mouse bone marrow mesenchymal stromal cell subpopulations with distinct lineage commitment |
Q55065461 | Donor variability among anti-inflammatory pre-activated mesenchymal stromal cells. |
Q38107626 | Epigenetic control of cytokine gene expression: regulation of the TNF/LT locus and T helper cell differentiation |
Q49178540 | Extracellular GC-rich DNA activates TLR9- and NF-kB-dependent signaling pathways in human adipose-derived mesenchymal stem cells (haMSCs). |
Q48189326 | Identification of IL-1β and LPS as optimal activators of monolayer and alginate-encapsulated mesenchymal stromal cell immunomodulation using design of experiments and statistical methods. |
Q38803607 | Immunomodulatory effect of mesenchymal stem cells on the immune response of macrophages stimulated by Aspergillus fumigatus conidia |
Q30989014 | Improvement of the cell-loading efficiency of biomaterials by inoculation with stem cell-based microspheres, in osteogenesis. |
Q46044549 | LIGHT regulates the adipogenic differentiation of mesenchymal stem cells |
Q38175951 | Mesenchymal stem cell therapy for cardiac inflammation: immunomodulatory properties and the influence of toll-like receptors. |
Q34144015 | Mesenchymal stem cells exert anti-proliferative effect on lipopolysaccharide-stimulated BV2 microglia by reducing tumour necrosis factor-α levels |
Q51541405 | Mesenchymal stem cells promote macrophage polarization toward M2b-like cells. |
Q40930999 | Mesenchymal stromal cell-dependent reprogramming of Kupffer cells is mediated by TNF-α and PGE2 and is crucial for liver transplant tolerance |
Q37612073 | Mouse Mesenchymal Progenitor Cells Expressing Adipogenic and Osteogenic Transcription Factors Suppress the Macrophage Inflammatory Response. |
Q35551433 | Mouse aorta-derived mesenchymal progenitor cells contribute to and enhance the immune response of macrophage cells under inflammatory conditions |
Q90411548 | Oral Mesenchymal Stem/Progenitor Cells: The Immunomodulatory Masters |
Q48133041 | Porphyromonas gingivalis lipopolysaccharides affect gingival stem/progenitor cells attributes through NF-κB, but not Wnt/β-catenin, pathway |
Q90150467 | Preconditioning of Rat Bone Marrow-Derived Mesenchymal Stromal Cells with Toll-Like Receptor Agonists |
Q52714326 | Specific ADAM10 inhibitors localize in exosome-like vesicles released by Hodgkin lymphoma and stromal cells and prevent sheddase activity carried to bystander cells. |
Q27324514 | Tissue-engineered autologous grafts for facial bone reconstruction |
Q38979891 | miRNA-1246 induces pro-inflammatory responses in mesenchymal stem/stromal cells by regulating PKA and PP2A. |